M. Abdul Jalil, S. Md. Masum / Tetrahedron Letters 53 (2012) 3049–3051
3051
Me3Si
OH
O
O
N
N
KF
5 mol% LiBr
neat, rt, 30 h
N
N
+
N
N
Me
Me
Me
SiMe3
MeOH,3 h
5
6 (68%)
Scheme 3. Synthesis of imidazolyl alcohol 6 using an alkyl-substituted unsymmetric epoxide.
SiMe3
OH
O
O
N
N
KF
5 mol% LiBr
+
N
N
MeOH,3 h
neat, 60 °C, 8 h
SiMe3
N
N
7
8 (81%)
Scheme 4. Synthesis of an imidazolyl alcohol using a symmetric internal epoxide.
Process Res. Dev. 2001, 5, 467–471; (d) Pouget, C.; Fagnere, C.; Basly, J. P.;
Habrioux, G.; Chulia, A. J. Bioorg. Med. Chem. Lett. 2002, 12, 2859–2861.
4. (a) Godefroi, E.; Heeres, J.; Van Cutsem, J.; Janssen, P. J. Med. Chem. 1969, 12,
784; (b) Armando, R.; Simone, B.; Annalina, L.; Marco, M.; Adriano, M.; Simona,
R.; Esperanza, H.; Bruno, M. J. Med. Chem. 2002, 45, 4903; (c) Polak, A. Arzneim.-
Forsch. 1982, 32, 17–24; (d) Polak, A. Sabouradia 1983, 21, 205–213; (e)
Gabriella, De M.; Guiseppe, La R.; Di Alessandra, P.; Rino, R.; Alberto, B.; Chiara,
C.; Anna, S.; Giovanni, M.; Emmanuele, C.; Marino, A.; Romano, S. J. Med. Chem.
2005, 48, 4378.
5. (a) Kotsuki, H.; Wakao, M.; Hayakawa, H.; Shimanouchi, T.; Shiro, M. J. Org.
Chem. 1996, 61, 984; (b) Kotsuki, H.; Wakao, M.; Hayakawa, H.; Shimanouchi,
T.; Shiro, M. J. Org. Chem. 1996, 61, 8915; (c) Kotsuki, H.; Hayakawa, H.; Wakao,
M.; Shimanouchi, T.; Ochi, M. Tetrahedron: Asymmetry 1995, 6, 2665.
6. Arnold, P. L.; Rodden, M.; Davis, K. M.; Scarisbrick, A. C.; Black, A. J.; Wilson, C.
Chem. Commun. 2004, 1612.
The stereochemistry of the ring-opened product 8 was found to
be trans. The spectral data (1H and 13C) were similar to those of the
reported compound.5,15
A plausible mechanism for the LiBr-catalyzed epoxide ring-
opening with silylated imidazole is depicted in Figure 2.
Coordination of the epoxide oxygen to Li+ (TS-I) renders the
epoxide susceptible to nucleophilic attack by the silylated imidaz-
ole leading to TS-II. Subsequent intra or intermolecular silyl trans-
fer resulted in formation of the imidazolyl silyl ether and liberation
of the catalyst.
In conclusion, we have described an efficient general catalytic
method for the preparation of biologically important imidazolyl
alcohols via an epoxide ring-opening reaction. The advantages of
this method are that the reactions are carried out under mild con-
ditions in short times, with excellent stereo- and regioselectivity,
using an inexpensive, user friendly, non-toxic catalyst. The sol-
vent-free reaction conditions combined with simple experimental
and product isolation procedures is expected to contribute to the
development of an environmentally friendly (assuming no toxic
organic solvents are used in the work-up/column chromatography)
process for the synthesis of biologically and catalytically important
imidazolyl alcohols.
7. (a) Arnold, P. L.; Scarisbrick, A. C.; Black, A. J.; Rodden, M.; Wilson, C. Chem.
Commun. 2001, 2340; (b) Arnold, P. L.; Mungur, S. A.; Black, A. J.; Wilson, C.
Angew. Chem., Int. Ed. 2003, 42, 5981.
8. Demberelnyamba, D.; Yoon, S. J.; Lee, H. Chem. Lett. 2004, 33, 560.
9. (a) Johnson, R. A.; Sharpless, K. B. In Catalytic Asymmetric Synthesis; Ojima, I.,
Ed.; VCH: New York, 1993. Chapter 4.1; (b) Jacobsen, E. N. Ibid. Chapter 4.2.
10. See for examples: (a) Yamamoto, Y.; Asao, N.; Meguro, M.; Tsukade, N.;
Nemoto, H.; Adayari, N.; Wilson, J. G.; Nakamura, H. J. Chem. Soc., Chem.
Commun. 1993, 1201–1203; (b) Meguro, M.; Asao, N.; Yamamoto, Y. J. Chem.
Soc., Perkin Trans. 1 1994, 2597; (c) Chini, M.; Crotti, P.; Favero, L.; Macchia, F.;
Pineschi, M. Tetrahedron Lett. 1994, 35, 433; (d) Auge, J.; Leroy, F. Tetrahedron
Lett. 1996, 37, 7715; (e) Rampalli, S.; Chaudhari, S. S.; Akamanchi, K. G.
Synthesis 2000, 7; (f) Curini, M.; Epifano, F.; Marcotullio, M. C.; Rosati, O. Eur. J.
Org. Chem. 2001, 4149; (g) Harrak, Y.; Pujol, M. D. Tetrahedron Lett. 2002, 43,
819; (h) Reddy, L. R.; Reddy, M. A.; Bhanumathi, N.; Rao, K. R. Synthesis 2001,
831–832.
Acknowledgment
11. Glas, H.; Thiel, W. R. Tetrahedron Lett. 1998, 38, 5509.
12. (a) Tanaka, K.; Toda, F. In Solvent-free Organic Synthesis; Wiley-VCH, 2003; (b)
Cave, G. W. V.; Raston, C. L.; Scott, J. L. Chem. Commun. 2001, 2159–2169; (c)
Varma, R. S. Pure Appl. Chem. 2001, 73, 193–198; (d) Tanaka, K.; Toda, F. Chem.
Rev. 2000, 100, 1025–1074; (e) Varma, R. S. Green Chem. 1999, 43–55; (f)
Metzger, J. O. Angew. Chem., Int. Ed. 1998, 37, 2975–2978.
We gratefully thank Dr. Tapan Kumar Chakraborti of the Presi-
dency University for his support.
13. Synthesis of (R)-2: A 2-necked flask equipped with a stopper and a rubber
septum was charged with LiBr (0.022 g, 5 mol %) in a glove box. It was then
Supplementary data
connected to
a vacuum line and heat applied using a heating gun with
Supplementary data (synthetic and spectroscopic data for com-
pounds 2, 4, 6, and 8) associated with this article can be found, in
occasional shaking of the flask in order to accumulate LiBr at the bottom of the
flask. The flask was then filled with N2 and epichlorohydrin (0.46 g, 2.5 mmol)
was added via syringe and the mixture stirred for 10 min. Silyl imidazole
(0.70 g, 2.5 mmol) was added via syringe and stirring was continued for 6 h at
room temperature. KF (2.7 mmol) and MeOH (10 ml) were added and the
mixture stirred for 3 h. The solvents were removed in vacuo and the remaining
oily residue was purified by column chromatography using silica gel (CH2Cl2/
References and notes
MeOH = 9:1). Yield 82% (white solid); mp 89.0–91.0 °C; IR (KBr, cmÀ1
) m; 3117,
1. Rosello, A.; Bertini, S.; Lapucci, A.; Macchia, M.; Martinelli, A.; Rapposelli, S.;
Herreros, E.; Macchia, B. J. Med. Chem. 2002, 45, 4903–4912; (b) Sheehan, D. J.;
Hitchcock, C. A.; Sibley, C. M. Clin. Microbiol. Rev. 1999, 12, 40–79; (c) Lartey, P.
A.; Moehle, C. M. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.;
Academic Press: New York, 1997; Vol. 32, pp 151–169; (d) Botta, M.; Corelli, F.;
Gasparrini, F.; Messina, F.; Mugnaini, C. J. Org. Chem. 2000, 65, 4736–4739.
2. (a) Eicher, T.; Hauptmann, S. The Chemistry of Heterocycles; Georg Thieme
Verlag: New York, 1995; (b)Medicinal Chemistry: Principles and Practice; King, F.
D., Ed.; Royal Society of Chemistry: Cambridge, England, 1994; pp 191–202.
3. (a) Freyne, D.; Raeymaekers, A.; Venet, M.; Sanz, G.; Wouters, W.; De Coster, R.;
Wauwe, J. V. Bioorg. Med. Chem. Lett. 1998, 8, 267–272; (b) Njar, V. C. O.; Nnane,
I. P.; Brodie, A. M. H. Bioorg. Med. Chem. Lett. 2000, 10, 1905–1908; (c)
Aelterman, W.; Lang, Y.; Willemsens, B.; Vervest, I.; Leurs, S.; De Knaep, F. Org.
1597, 1511, 1440; 1H NMR (400 MHz, CDCl3): d = 3.27 (m, 1H; CH2Cl), 3.40 (m,
1H, CH2Cl), 3.90 (m, 2H, ImCH2 and CHOH), 4.05 (m, 1H, ImCH2), 5.54 (br d, 1H,
OH), 6.74 (s, 1H, NCHN), 6.84 (s, 1H, NCH), 7.31 (s, 1H, NCH), 13C NMR
(100 MHz, CDCl3): d = 45.41 (s, CH2Cl), 50.28 (s, ImCH2), 70.00 (s, CHOH),
120.15 (s, NCH), 127.90 (s, NCH), 137.60 (s, NCH); MS (ESI): m/z (%): 161.1 (M+,
90), 90.9 (20), 68.97 (100); Anal. Calcd for C6H9ClN2O: C 44.87, H 5.65, N 17.44.
Found: C 44.67, H 5.72, N 17.09.
14. (a) Basak, A.; Nayak, M. K.; Chakraborti, A. K. Tetrahedron Lett. 1998, 39, 4883–
4886; (b) Chakraborti, A. K.; Basak, A.; Grover, V. J. Org. Chem. 1999, 64, 8014–
8017; (c) Chakraborti, A. K.; Rudrawar, S.; Kondaskar, A. Eur. J. Org. Chem. 2004,
3597–3600.
15. Murabayashi, A.; Mukisumi, Y. Heterocycles 1990, 31, 537.